抗脂药物与肾病性高脂血症 - Suppr | 超能文献

Antilipaemic drugs and nephrotic hyperlipidaemia.

作者信息

Edwards K D

出版信息

Prog Biochem Pharmacol. 1972;7:370-426.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Antilipaemic drugs and nephrotic hyperlipidaemia.抗脂药物与肾病性高脂血症

Prog Biochem Pharmacol. 1972;7:370-426.

2

Factorial study of the efficacy of cholestyramine, L-tryptophan and clofibrate in human nephrotic hyperlipidaemia.消胆胺、L-色氨酸和氯贝丁酯治疗人类肾病性高脂血症疗效的析因研究。

Prog Biochem Pharmacol. 1974;9:82-98.

3

[Nephrotic hyperlipidemia and its clinical significance].[肾病性高脂血症及其临床意义]

Ter Arkh. 1990;62(6):150-3.

4

Lipid abnormalities in the nephrotic syndrome: the therapeutic role of statins.肾病综合征中的脂质异常：他汀类药物的治疗作用

J Nephrol. 2001 Nov-Dec;14 Suppl 4:S70-5.

5

[Lipolytic activity of kidney tissue in experimental nephrotic syndrome].[实验性肾病综合征中肾脏组织的脂解活性]

Vopr Med Khim. 1967 Jul-Aug;13(4):404-8.

6

[Therapy of hyperlipidemia].[高脂血症的治疗]

Dtsch Gesundheitsw. 1971 Oct 21;26(43):2020-4.

7

Clofibrate and androsterone effect on serum lipids.

Arch Intern Med. 1967 Jan;119(1):80-5.

8

[Hyperlipemia in nephrotic syndrome].[肾病综合征中的高脂血症]

Pol Tyg Lek. 1972 Jan 31;27(5):189-91.

9

[The treatment of essential hyperlipidemia with clofibrate].

Z Gesamte Inn Med. 1969 Jan 1;24(1):Suppl:184-7.

10

[Evaluation of the antilipaemic potential of etofylline clofibrate, its metabolites and clofibrate in dietary-induced hyperlipidaemia in the rat (author's transl)].[益多酯、其代谢产物及氯贝丁酯对大鼠饮食诱导性高脂血症的降血脂潜力评估（作者译）]

Arzneimittelforschung. 1980;30(11b):2038-41.

引用本文的文献

1

Lipoprotein lipid and protein synthesis in experimental nephrosis and plasmapheresis: II. Perfused rat liver.实验性肾病和血浆置换中的脂蛋白脂质与蛋白质合成：II. 灌注大鼠肝脏

Lipids. 1980 Sep;15(9):637-43. doi: 10.1007/BF02534013.

2

Lipid metabolism in plasma, liver, and adipose tissue of rats with experimental chronic nephrotic syndrome.实验性慢性肾病综合征大鼠血浆、肝脏及脂肪组织中的脂质代谢

Lipids. 1977 Feb;12(2):208-14. doi: 10.1007/BF02533296.